Simon JacobM.D.

Furrer D, Dragic D, Chang SL, Fournier F, Droit A, Jacob S, Diorio C

Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review

Cancer Drug Resist, 5 (4), 2022.

Résumé | Liens:

Burguin A, Furrer D, Ouellette G, Jacob S, Diorio C, Durocher F

Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines

PLoS One, 15 (6), 2020.

Résumé | Liens:

Vincent G, Richebourg S, Cloutier S, Fortin M, Jacob S, Amin-Hashem M

Large B-Cell Lymphoma With IRF4 Rearrangement: From Theory to Practice

AJSP Rev Rep, 24 (5), 2019.

| Liens:

Hanna M, Dumas I, Orain M, Jacob S, Tetu B, Diorio C

Association between physical activity and the expression of mediators of inflammation in normal breast tissue among premenopausal and postmenopausal women

Cytokine, 102 , 2018.

Résumé | Liens:

Poirier É, Desbiens C, Poirier B, Boudreau D, Jacob S, Lemieux J, Doyle C, Diorio C, Hogue JC, Provencher L

Characteristics and long-term survival of patients diagnosed with pure tubular carcinoma of the breast

J Surg Oncol, 117 (6), 2018.

Résumé | Liens:

Poirier E, Desbiens C, Poirier B, Boudreau D, Jacob S, Lemieux J, Doyle C, Diorio C, Hogue JC, Provencher L

In response to: Long-term overall survival of patients diagnosed with pure tubular carcinoma of the breast might be affected by increased co-morbidities

J Surg Oncol, 117 (7), 2018.

| Liens:

Furrer D, Jacob S, Michaud A, Provencher L, Lemieux J, Diorio C

Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients

Clin Breast Cancer, 18 (4), 2018.

Résumé | Liens:

Slim FA, Ouellette G, Ennour-Idrissi K, Jacob S, Diorio C, Durocher F

An isoform of AIF1 involved in breast cancer

Cancer Cell Int, 18 , 2018.

Résumé | Liens:

Kothari C, Ouellette G, Labrie Y, Jacob S, Diorio C, Durocher F

Identification of a gene signature for different stages of breast cancer development that could be used for early diagnosis and specific therapy

Oncotarget, 9 (100), 2018.

Résumé | Liens:

Furrer D, Jacob S, Caron C, Sanschagrin F, Provencher L, Diorio C

Concordance of HER2 Immunohistochemistry and Fluorescence In Situ Hybridization Using Tissue Microarray in Breast Cancer

Anticancer Res, 37 (6), 2017.

Résumé | Liens: